ACADIA PHARMACEUTICALS A/S
CVR number: 19670694
Bagsværd Hovedgade 141, 2880 Bagsværd
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -74.71 | -56.87 | -21.17 | - 253.52 | - 151.40 |
| Gross profit | -74.71 | -56.87 | -21.17 | - 253.52 | - 151.40 |
| EBIT | -74.71 | -56.87 | -21.17 | - 253.52 | - 151.40 |
| Other financial expenses | -0.03 | -0.06 | |||
| Pre-tax profit | -74.71 | -56.87 | -21.20 | - 253.58 | - 151.40 |
| Net earnings | -74.71 | -56.87 | -21.20 | - 253.58 | - 151.40 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Short term receivables total | |||||
| Cash and bank deposits | 2.54 | 10.97 | 6.47 | 4.89 | 3.50 |
| Cash and cash equivalents | 2.54 | 10.97 | 6.47 | 4.89 | 3.50 |
| Balance sheet total (assets) | 2.54 | 10.97 | 6.47 | 4.89 | 3.50 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 601.00 | 601.00 | 601.00 | 601.00 | 601.00 |
| Retained earnings | -1 036.03 | -1 110.73 | -1 167.60 | -1 188.80 | -1 442.38 |
| Profit of the financial year | -74.71 | -56.87 | -21.20 | - 253.58 | - 151.40 |
| Shareholders equity total | - 509.73 | - 566.60 | - 587.80 | - 841.38 | - 992.77 |
| Non-current liabilities total | |||||
| Current trade creditors | 20.30 | ||||
| Current owed to group member | 512.27 | 557.27 | 594.27 | 846.27 | 996.27 |
| Current liabilities total | 512.27 | 577.57 | 594.27 | 846.27 | 996.27 |
| Balance sheet total (liabilities) | 2.54 | 10.97 | 6.47 | 4.89 | 3.50 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.